AI assistant
EXELIXIS, INC. — Director's Dealing 2025
Feb 27, 2025
30561_dirs_2025-02-26_7602ab8c-dc5c-4959-9e7e-27582c8bef79.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2025-02-24
Reporting Person: Senner Christopher J. (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-24 | Common Stock | M | 29314 | $18.80 | Acquired | 808921 | Direct |
| 2025-02-24 | Common Stock | S | 29314 | $36.14 | Disposed | 779607 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-24 | Option (right to buy) | $18.80 | M | 29314 | Disposed | 2025-09-09 | Common Stock (29314) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2723 | Indirect |
Footnotes
F1: Includes 266,700 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic
equivalent of one share of Common Stock.
F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.11 to $36.21. Reporting Person undertakes to provide Exelixis, Inc., any security
holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in
footnote 2 to this Form 4.
F3: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 24, 2025.
F4: The option, representing the right to purchase a total of 129,314 shares of Common Stock, became fully exercisable on September 10, 2022.